Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.390
+0.030 (1.27%)
At close: Dec 15, 2025, 4:00 PM EST
2.390
0.00 (0.00%)
After-hours: Dec 15, 2025, 7:52 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $230.07 million as of December 15, 2025. Its market cap has increased by 94.51% in one year.
Market Cap
230.07M
Enterprise Value
95.92M
1-Year Change
94.51%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $230.07M, a decrease of -2.32%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 227.19M | 104.76% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | 300.21M | -10.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |